• to lower the chance of serious cardiovascular (heart and blood vessel) issues in adults with variety 2 diabetes and heart problemsIn Oct 2024, Novo Nordisk published a research on scientific journal Mother nature a few novel glucose-sensitive insulin NNC2215 that could lower the risk of hypoglycemia in animal versions.[67]This deficiency of tra